136 related articles for article (PubMed ID: 11012743)
1. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Leder LD; Schaefer HE
Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
[TBL] [Abstract][Full Text] [Related]
2. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
[TBL] [Abstract][Full Text] [Related]
3. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
[TBL] [Abstract][Full Text] [Related]
4. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Spohr M; Diehl V; Zankovich R; Niederle N; Leder LD
Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patients.
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Diehl V; Zankovich R; Niederle N; Leder LD; Schaefer HE
Br J Haematol; 2001 Mar; 112(3):727-39. PubMed ID: 11260078
[TBL] [Abstract][Full Text] [Related]
6. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V
Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
[TBL] [Abstract][Full Text] [Related]
7. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
Thiele J; Zirbes T; Kvasnicka HM; Niederle N; Dammasch J; Schmidt M; Windecker R; Leder LD; Diehl V; Fischer R
Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
[TBL] [Abstract][Full Text] [Related]
9. The impact of megakaryocyte proliferation of the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia.
Buhr T; Choritz H; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):473-8. PubMed ID: 1609507
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Goekce D; Diehl V; Zankovich R; Schaefer HE
J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Diehl V; Zankovich R; Niederle N; Leder LD; Schaefer HE
J Clin Oncol; 2001 Jun; 19(12):2994-3009. PubMed ID: 11408494
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in-situ hybridization (FISH) reveals that in chronic myelogenous leukaemia (CML) following interferon-alpha therapy, normalization of megakaryocyte size is associated with the loss of bcr/abl translocation.
Thiele J; Schmitz B; Gross H; Kvasnicka HM; Niederle N; Leder LD; Fischer R
Histopathology; 1997 Sep; 31(3):215-21. PubMed ID: 9354890
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zirbes TK; Birnbaum F; Kressmann C; Melguizo-Grahmann M; Frackenpohl H; Sprungmann C; Leder LD; Diehl V; Zankovich R; Schaefer HE; Niederle N; Fischer R
Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
[TBL] [Abstract][Full Text] [Related]
14. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
Thiele J; Simon KG; Fischer R; Zankovich R
Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
[TBL] [Abstract][Full Text] [Related]
15. Histological and clinical evolution patterns of chronic myelocytic leukemia.
Varma N; Varma S; Marwaha N; Garewal G
Indian J Cancer; 1997 Dec; 34(4):164-8. PubMed ID: 9715539
[TBL] [Abstract][Full Text] [Related]
16. Polycythaemia vera: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan.
Kreft A; Nolde C; Büsche G; Buhr T; Kreipe H; Georgii A
Eur J Haematol; 2000 Jan; 64(1):32-41. PubMed ID: 10680703
[TBL] [Abstract][Full Text] [Related]
17. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
Katayama T; Masuoka H; Yoshida M; Watanabe R; Nishiwaki K; Shimada T; Kaito K; Ochiai S; Kobayashi M; Sakai O
Rinsho Ketsueki; 1992 Apr; 33(4):488-93. PubMed ID: 1602613
[TBL] [Abstract][Full Text] [Related]
18. [Histopathology of chronic myeloid leukemia in diagnostic biopsies of bone marrow].
Büsche G; Buhr T; Georgii A
Pathologe; 1995 Jan; 16(1):70-4. PubMed ID: 7886017
[TBL] [Abstract][Full Text] [Related]
19. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia.
Thiele J; Kvasnicka HM
Leuk Lymphoma; 2001; 42(5):855-62. PubMed ID: 11697640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
